quinazolines has been researched along with Hemangiosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chanana, P; Dood, R; Haemmerle, M; Holland, EC; Lazar, AJ; Lyons, YA; Mangala, LS; Nagaraja, AS; Ravi, V; Siedel, JH; Sood, AK; Wagner, MJ; Wang, WL | 1 |
1 other study(ies) available for quinazolines and Hemangiosarcoma
Article | Year |
---|---|
Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hemangiosarcoma; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Prognosis; Pyridones; Pyrimidinones; Quinazolines; Transcriptome; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2021 |